文献速递急性肾损伤慢性肾脏病

顺铂肾损伤的潜在治疗靶点:来自其他急性肾损伤与纤维化模型的启示

Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis.
PubMed 文献 · J Am Soc Nephrol · 2021-05-28

顺铂可导致30%患者发生急性肾损伤,未达临床AKI标准者仍有长期肾功能下降和慢性肾脏病风险。本文综述多种啮齿动物模型中预防肾损伤及其纤维化进展的策略,揭示细胞死亡、衰老、内质网应激、自噬和免疫细胞活化在急慢性肾损伤中的复杂作用,强调需多模型开发覆盖顺铂肾损伤全方面的药物。

要点

  • 顺铂导致30%患者发生AKI,未达AKI标准者仍有长期肾功能下降和CKD风险。
  • 肾纤维化是CKD的标志,但反复低剂量顺铂致纤维化的机制尚不清楚。
  • 细胞死亡、衰老、内质网应激、自噬和免疫活化在急慢性肾损伤中作用复杂。

核心结论

  • 综述多种啮齿动物模型的结果提示,细胞死亡、细胞衰老、内质网应激、自噬和免疫细胞活化在顺铂所致急性与慢性肾损伤中具有多样且高度复杂的作用。
  • 开发能预防顺铂肾损伤所有方面的药物需要采用多种肾损伤模型。

研究设计与样本

  • 本文为综述,检索并汇总多种啮齿动物模型中预防肾损伤、其进展至纤维化或两者的策略,以获取机制见解并识别顺铂肾病理的潜在治疗靶点。

主要发现

  • 顺铂导致30%患者发生AKI。
  • 未达临床AKI标准的患者仍有长期肾功能下降和发生CKD的风险。
  • 肾纤维化是CKD发展的标志。
  • 反复低剂量顺铂导致纤维化发展的机制所知甚少。

临床怎么用

  • 临床应关注顺铂治疗患者即使未达AKI标准仍存在的长期肾功能下降和CKD风险。
  • 药物开发需采用多种肾损伤模型以覆盖顺铂肾损伤的急性和慢性方面。

局限性

  • 综述基于啮齿动物模型的结果,向临床转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The effectiveness of cisplatin, a mainstay in the treatment of many solid organ cancers, is hindered by dose-limiting nephrotoxicity. Cisplatin causes AKI in 30% of patients. Patients who do not develop AKI by clinical standards during treatment are still at risk for long-term decline in kidney function and the development of CKD. The connection between AKI and CKD has become increasingly studied, with renal fibrosis a hallmark of CKD development. To prevent both the short- and long-term effects of cisplatin, researchers must use models that reflect both types of pathology. Although a lot is known about cisplatin-induced AKI, very little is known about the mechanisms by which repeated low levels of cisplatin lead to fibrosis development. In this review, strategies used in various rodent models to prevent kidney injury, its progression to fibrosis, or both, are examined to gain mechanistic insights and identify potential therapeutic targets for cisplatin-induced kidney pathologies. Reviewing the results from these models highlights the diverse and highly complex role of cell death, cell senescence, endoplasmic reticulum stress, autophagy, and immune cell activation in acute and chronic kidney injuries. The use of several models of kidney injury is needed for development of agents that will prevent all aspects of cisplatin-induced kidney injury.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sears SM, Siskind LJ. Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis. J Am Soc Nephrol. 2021. PMID: 34049962. doi:10.1681/ASN.2020101455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。